Microbot Medical (MBOT) Competitors

STRATA Skin Sciences (NASDAQ:SSKN) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends, community ranking and analyst recommendations.

Is SSKN or MBOT more profitable?

Microbot Medical has a net margin of 0.00% compared to Microbot Medical's net margin of -20.40%. Microbot Medical's return on equity of -38.76% beat STRATA Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STRATA Skin Sciences	-20.40%	-38.76%	-14.12%
Microbot Medical	N/A	-146.17%	-119.20%

Do analysts prefer SSKN or MBOT?

STRATA Skin Sciences presently has a consensus target price of $3.80, indicating a potential upside of 590.41%. Microbot Medical has a consensus target price of $8.00, indicating a potential upside of 540.00%. Given Microbot Medical's higher possible upside, research analysts plainly believe STRATA Skin Sciences is more favorable than Microbot Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STRATA Skin Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Microbot Medical	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media refer more to SSKN or MBOT?

In the previous week, STRATA Skin Sciences and STRATA Skin Sciences both had 2 articles in the media. Microbot Medical's average media sentiment score of 1.43 beat STRATA Skin Sciences' score of 0.63 indicating that STRATA Skin Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STRATA Skin Sciences	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation and earnings, SSKN or MBOT?

STRATA Skin Sciences has higher revenue and earnings than Microbot Medical. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STRATA Skin Sciences	$36.16M	0.53	-$5.55M	-$0.20	-2.75
Microbot Medical	N/A	N/A	-$13.17M	-$1.48	-0.84

Does the MarketBeat Community believe in SSKN or MBOT?

Microbot Medical received 122 more outperform votes than STRATA Skin Sciences when rated by MarketBeat users. Likewise, 70.55% of users gave Microbot Medical an outperform vote while only 63.90% of users gave STRATA Skin Sciences an outperform vote.

Company	Underperform	Outperform
STRATA Skin Sciences	Outperform Votes 223 63.90%	Underperform Votes 126 36.10%
Microbot Medical	Outperform Votes 345 70.55%	Underperform Votes 144 29.45%

Which has more volatility & risk, SSKN or MBOT?

STRATA Skin Sciences has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 3.14, meaning that its stock price is 214% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in SSKN or MBOT?

47.5% of STRATA Skin Sciences shares are owned by institutional investors. Comparatively, 15.2% of Microbot Medical shares are owned by institutional investors. 40.4% of STRATA Skin Sciences shares are owned by company insiders. Comparatively, 10.6% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

STRATA Skin Sciences beats Microbot Medical on 9 of the 15 factors compared between the two stocks.